ClinicalTrials.gg
RecruitingNCT05778552Updated Mar 21, 2023

The Intermediate and Long-term Follow up of Home Based Pelvic Muscle Training

An observational study in Pelvic Floor Disorders, Pelvic Organ Prolapse and Stress Urinary Incontinence, sponsored by Taipei Veterans General Hospital, Taiwan. Recruiting at 1 site in Taiwan. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-03-21.

Sponsored by Taipei Veterans General Hospital, Taiwan · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Ages
18 Years and older
Sex
Female
01

Study summary

When participants present with symptoms of pelvic organ prolapse (POP) and stress urinary incontinence (SUI), the investigators will perform a comprehensive evaluation and initially provide conservative treatment. If conservative treatment fails, invasive treatment will be considered. The investigators will arrange a pelvic muscle training course two to three times a week for a duration of 1.5 months per course. However, participants may complain about the inconvenience of traffic, which may lead to discontinuation of the pelvic training course. Therefore, the investigators propose the development of a home-based pelvic muscle training device and will collaborate with information engineering specialists at Tamkang University to invent the device for home-based pelvic muscle training.

Read the detailed description

The investigators will enroll participants with SUI or POP and allocate them into either the home-based pelvic floor muscle training (PFMT) group or traditional PFMT group. Participant satisfaction will be evaluated using a questionnaire score.

02

Conditions studied

  • Pelvic Floor Disorders
  • Pelvic Organ Prolapse
  • Stress Urinary Incontinence
03

In context

Pelvic Floor Disorders

212 studies on the registry are indexed under Pelvic Floor Disorders; 46 are open to participants now.

This study's planned enrollment of 200 is above the median of 161 across 60 observational studies indexed under Pelvic Floor Disorders.

Browse Pelvic Floor Disorders studies →

Lead sponsor

Taipei Veterans General Hospital, Taiwan is the lead sponsor of 338 studies on the registry; 74 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Women with SUI and Pelvic organ prolapse could be enrolled for study

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age > 18-year-old, non-pregnancy, SUI, bladder capacity > 300ml, RU\<150ml, pelvic organ prolapse

Exclusion criteria

Exclusion Criteria:

  • recurrent UTI, cancer patients, chronic pelvic pain, psychologic problems
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No

Groups and cohorts

  • Home-based pelvic muscle training devices group

    Patients underwent pelvic muscle training by home-based device and at home.

    Device: Home-based pelvic muscle training devices or traditional PFMT at hospital

  • Traditional pelvic muscle training devices group

    Patients underwent traditional pelvic muscle training at hospital

    Device: Home-based pelvic muscle training devices or traditional PFMT at hospital

Interventions

  • DeviceHome-based pelvic muscle training devices or traditional PFMT at hospital

    Performed home-based pelvic muscle training devices at home or traditional PFMT at hospital

06

What researchers measure

Primary outcomes

  1. The satisfication of pelvic muscle training (UDI-6)

    The total score ranges from 0 to 18, with a higher score indicating that the patient experiences a greater degree of urinary distress.

    Time frame: up to 2 years

  2. The satisfication of pelvic muscle training (ICIQ-SF)

    The total score ranges from 0 to 21, with a higher score indicating that the patient experiences a greater degree of urinary distress.

    Time frame: up to 2 years

  3. The satisfication of pelvic muscle training (IIQ-7)

    The total score ranges from 0 to 21, with a higher score indicating that the patient experiences a greater degree of urinary distress.

    Time frame: up to 2 years

  4. The satisfication of pelvic muscle training (POPDI-6)

    POPDI-6 scores range from 0 to 24 and higher scores indicate worse bulging symptoms

    Time frame: up to 2 years

  5. The satisfication of pelvic muscle training (PISQ-IR)

    The PISQ-IR is a validated questionnaire in research for assessment of female sexual function. A higher score indicates a greater negative impact on sexual function.

    Time frame: up to 2 years

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Apr 2023; primary completion for Dec 2025, 32 months later.

Of 26 observational studies under Pelvic Floor Disorders, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 45. This study's planned 32 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 20, 2023
First posted
Mar 21, 2023
StartEst.
Apr 1, 2023
Primary completionEst.
Dec 31, 2025
CompletionEst.
Dec 31, 2026
Last update
Mar 21, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 21, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05778552
Responsible party
Sponsor
First posted
Mar 21, 2023
Start date
Apr 1, 2023 (estimated)
Primary completion
Dec 31, 2025 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Mar 21, 2023

Study contacts

Huann-Cheng Horng
Contact
hchorng@vghtpe.gov.tw
886-(2) 2875-7826
Huann-Cheng Horng
principal investigator · Taipei Veterans General Hospital, Taiwan

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion